Peculiarities of the EEU countries interaction in pharmaceutical value chains in pandemic period

¹ Ural Federal University named after the First President of Russia B.N. Yeltsin, Mira Str., 19, 620002 Ekaterinburg, Russia
² Institute of Economics, Ural Branch of the Russian Academy of Sciences, Moskovskaya Str., 29, 620014 Ekaterinburg, Russia
³ Karaganda University of Kazpotrebsouz, Academic Str., 9, 100009 Karaganda, Kazakhstan

^* Corresponding author: frol-uved@yandex.ru

Abstract

Taking into account that new trends are emerging in the field of international economic integration in pandemic world the authors aimed to study the role of the country's participation in global value chains (GVCs) in the development of the Eurasian Economic Union (EEU or EAEU) national pharmaceutical industry. The article reveals the contradictory essence of modern concepts of interaction between the countries of integration associations and GVCs including its specificity for the EEU. An analysis of the pharmaceutical industry in EEU before and in the pandemic is carried out, and the features of such interaction are revealed in more detail in Kazakhstan case. The results showed the presence of low volumes of pharmaceutical products in EEU intraregional trade and minimum presence in GVCs. The hypothesis was partially confirmed that the countries localized the GVC “production” stage on their territory received gain as the increase in domestic production in pandemic period, despite the fact that this stage corresponds to low added value. The novelty is in the development of a reproductive approach to the study of integration groups. Recommendations are given to increase the share of economic entities of the EEU countries in the process of forming regional value chains.